Baseline characteristics of first kidney-only transplant recipients by transplant cohort: Cohort 1, transplanted during 2005–06; Cohort 2, transplanted during 2007–08; Cohort 3, transplanted during 2009–10
| Characteristics . | 2005–06 . | 2007–08 . | 2009–10 . | % missing . |
|---|---|---|---|---|
| Number | 3702 | 3779 | 4286 | |
| Male, % | 62 | 63 | 63 | 0 |
| Age at transplantation (years), median (IQR) | 52 (42–61) | 52 (41–61) | 55 (44–63) | 0 |
| Dialysis time (years), median (IQR) | 3 (2–4) | 3 (2–5) | 3 (2–5) | 0 |
| Primary kidney disease, % | ||||
| DM types I and II | 10 | 10 | 12 | – |
| HTN/renovascular disease | 11 | 12 | 13 | – |
| Glomerulonephritis/sclerosis | 21 | 20 | 19 | – |
| Other | 26 | 26 | 24 | – |
| Missing/unknown | 31 | 32 | 32 | 32 |
| Initial KRT modality, % | ||||
| Dialysis | 79 | 81 | 81 | – |
| Kidney transplant | 12 | 15 | 18 | – |
| Missing/unknown | 9 | 4 | 0.7 | 4 |
| CIT (hours), median (IQR) | 17 (14–21) | 16 (13–20) | 16 (12–19) | 13 |
| Number of mismatches at HLA-A, B, DR | 0.5 | |||
| 0 | 12 | 12 | 11 | – |
| 1 | 8 | 6 | 5 | – |
| 2 | 28 | 22 | 21 | – |
| 3 | 32 | 35 | 37 | – |
| 4 | 16 | 20 | 20 | – |
| 5 | 4 | 4 | 4.8 | – |
| 6 | 1 | 1 | 1.5 | – |
| Panel reactive antibodies, % | 58 | |||
| 0 | 78 | 78 | 77 | – |
| >0–10 | 5 | 4 | 5 | – |
| 10–79 | 8 | 9 | 11 | – |
| >79 | 2 | 3 | 2 | – |
| Characteristics . | 2005–06 . | 2007–08 . | 2009–10 . | % missing . |
|---|---|---|---|---|
| Number | 3702 | 3779 | 4286 | |
| Male, % | 62 | 63 | 63 | 0 |
| Age at transplantation (years), median (IQR) | 52 (42–61) | 52 (41–61) | 55 (44–63) | 0 |
| Dialysis time (years), median (IQR) | 3 (2–4) | 3 (2–5) | 3 (2–5) | 0 |
| Primary kidney disease, % | ||||
| DM types I and II | 10 | 10 | 12 | – |
| HTN/renovascular disease | 11 | 12 | 13 | – |
| Glomerulonephritis/sclerosis | 21 | 20 | 19 | – |
| Other | 26 | 26 | 24 | – |
| Missing/unknown | 31 | 32 | 32 | 32 |
| Initial KRT modality, % | ||||
| Dialysis | 79 | 81 | 81 | – |
| Kidney transplant | 12 | 15 | 18 | – |
| Missing/unknown | 9 | 4 | 0.7 | 4 |
| CIT (hours), median (IQR) | 17 (14–21) | 16 (13–20) | 16 (12–19) | 13 |
| Number of mismatches at HLA-A, B, DR | 0.5 | |||
| 0 | 12 | 12 | 11 | – |
| 1 | 8 | 6 | 5 | – |
| 2 | 28 | 22 | 21 | – |
| 3 | 32 | 35 | 37 | – |
| 4 | 16 | 20 | 20 | – |
| 5 | 4 | 4 | 4.8 | – |
| 6 | 1 | 1 | 1.5 | – |
| Panel reactive antibodies, % | 58 | |||
| 0 | 78 | 78 | 77 | – |
| >0–10 | 5 | 4 | 5 | – |
| 10–79 | 8 | 9 | 11 | – |
| >79 | 2 | 3 | 2 | – |
Baseline characteristics of first kidney-only transplant recipients by transplant cohort: Cohort 1, transplanted during 2005–06; Cohort 2, transplanted during 2007–08; Cohort 3, transplanted during 2009–10
| Characteristics . | 2005–06 . | 2007–08 . | 2009–10 . | % missing . |
|---|---|---|---|---|
| Number | 3702 | 3779 | 4286 | |
| Male, % | 62 | 63 | 63 | 0 |
| Age at transplantation (years), median (IQR) | 52 (42–61) | 52 (41–61) | 55 (44–63) | 0 |
| Dialysis time (years), median (IQR) | 3 (2–4) | 3 (2–5) | 3 (2–5) | 0 |
| Primary kidney disease, % | ||||
| DM types I and II | 10 | 10 | 12 | – |
| HTN/renovascular disease | 11 | 12 | 13 | – |
| Glomerulonephritis/sclerosis | 21 | 20 | 19 | – |
| Other | 26 | 26 | 24 | – |
| Missing/unknown | 31 | 32 | 32 | 32 |
| Initial KRT modality, % | ||||
| Dialysis | 79 | 81 | 81 | – |
| Kidney transplant | 12 | 15 | 18 | – |
| Missing/unknown | 9 | 4 | 0.7 | 4 |
| CIT (hours), median (IQR) | 17 (14–21) | 16 (13–20) | 16 (12–19) | 13 |
| Number of mismatches at HLA-A, B, DR | 0.5 | |||
| 0 | 12 | 12 | 11 | – |
| 1 | 8 | 6 | 5 | – |
| 2 | 28 | 22 | 21 | – |
| 3 | 32 | 35 | 37 | – |
| 4 | 16 | 20 | 20 | – |
| 5 | 4 | 4 | 4.8 | – |
| 6 | 1 | 1 | 1.5 | – |
| Panel reactive antibodies, % | 58 | |||
| 0 | 78 | 78 | 77 | – |
| >0–10 | 5 | 4 | 5 | – |
| 10–79 | 8 | 9 | 11 | – |
| >79 | 2 | 3 | 2 | – |
| Characteristics . | 2005–06 . | 2007–08 . | 2009–10 . | % missing . |
|---|---|---|---|---|
| Number | 3702 | 3779 | 4286 | |
| Male, % | 62 | 63 | 63 | 0 |
| Age at transplantation (years), median (IQR) | 52 (42–61) | 52 (41–61) | 55 (44–63) | 0 |
| Dialysis time (years), median (IQR) | 3 (2–4) | 3 (2–5) | 3 (2–5) | 0 |
| Primary kidney disease, % | ||||
| DM types I and II | 10 | 10 | 12 | – |
| HTN/renovascular disease | 11 | 12 | 13 | – |
| Glomerulonephritis/sclerosis | 21 | 20 | 19 | – |
| Other | 26 | 26 | 24 | – |
| Missing/unknown | 31 | 32 | 32 | 32 |
| Initial KRT modality, % | ||||
| Dialysis | 79 | 81 | 81 | – |
| Kidney transplant | 12 | 15 | 18 | – |
| Missing/unknown | 9 | 4 | 0.7 | 4 |
| CIT (hours), median (IQR) | 17 (14–21) | 16 (13–20) | 16 (12–19) | 13 |
| Number of mismatches at HLA-A, B, DR | 0.5 | |||
| 0 | 12 | 12 | 11 | – |
| 1 | 8 | 6 | 5 | – |
| 2 | 28 | 22 | 21 | – |
| 3 | 32 | 35 | 37 | – |
| 4 | 16 | 20 | 20 | – |
| 5 | 4 | 4 | 4.8 | – |
| 6 | 1 | 1 | 1.5 | – |
| Panel reactive antibodies, % | 58 | |||
| 0 | 78 | 78 | 77 | – |
| >0–10 | 5 | 4 | 5 | – |
| 10–79 | 8 | 9 | 11 | – |
| >79 | 2 | 3 | 2 | – |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
